Quoin Pharmaceuticals
Tracked across 1 events · 7 articles · First seen Jul 09, 2026 · Last active Jul 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Quoin Pharmaceuticals received FDA IND clearance for QRX003 in Peeling Skin Syndrome, enabling a Phase 2 study. The company's stock fell over 8% in pre-market trading, reflecting mixed market sentiment.
Jul 09, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Quoin Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard